NSGC practice guideline: prenatal screening and diagnostic testing options for chromosome aneuploidy.
about
Non-Invasive Prenatal Testing Using Cell Free DNA in Maternal Plasma: Recent Developments and Future ProspectsRecent advances in prenatal genetic screening and testingSpanish- and English-Speaking Pregnant Women's Views on cfDNA and Other Prenatal Screening: Practical and Ethical Reflections.Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics.Pregnancy associated plasma protein-A2: a novel biomarker for Down syndrome.Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics.Comparing genetic counselor's and patient's perceptions of needs in prenatal chromosomal microarray testing.Obstetrician and Gynecologist Utilization of the Noninvasive Prenatal Testing Expanded Option.Non-invasive prenatal testing for aneuploidy: current status and future prospects.An Overview on Prenatal Screening for Chromosomal Aberrations.An update on current prenatal testing options: first trimester and noninvasive prenatal testing.Non-invasive prenatal testing for aneuploidy: a systematic review of Internet advertising to potential users by commercial companies and private health providers.Obstetricians and gynecologists' practice and opinions of expanded carrier testing and noninvasive prenatal testing.Nationwide survey for current clinical status of amniocentesis and maternal serum marker test in Japan.Frequency of fetal karyotype abnormalities in women undergoing invasive testing in the absence of ultrasound and other high-risk indications.Non-invasive prenatal testing with cell-free DNA: US physician attitudes toward implementation in clinical practice.Maternal cfDNA screening for Down syndrome--a cost sensitivity analysis.Isolated intracardiac echogenic focus on routine ultrasound: implications for practice.Application of Neural Networks for classification of Patau, Edwards, Down, Turner and Klinefelter Syndrome based on first trimester maternal serum screening data, ultrasonographic findings and patient demographics.A survey on awareness of genetic counseling for non-invasive prenatal testing: the first year experience in Japan.Clinical experience from Thailand: noninvasive prenatal testing as screening tests for trisomies 21, 18 and 13 in 4736 pregnancies.Implications of fetoplacental mosaicism on cell-free DNA testing: a review of a common biological phenomenon.Increased risk after noninvasive prenatal screening on cell-free DNA circulating in maternal blood: does a new indication for invasive prenatal diagnosis require new criteria for confirmatory cytogenetic analysis?Recent developments in genetics and medically assisted reproduction: from research to clinical applicationsEthical Concerns in the Implementation of DNA Sequencing-Based Noninvasive Prenatal Testing for Fetal Aneuploidy Among Obstetric Professionals in Hong KongNoninvasive Prenatal Testing: Implications for Muslim CommunitiesAttitude, knowledge and informed choice towards prenatal screening for Down Syndrome: a cross-sectional study
P2860
Q26827338-D5F23E3A-B72B-47D3-9122-68BEB43A2002Q28071888-3EDC55BE-3F40-43F0-AE07-0963EBEACC9AQ30197052-7ACBA737-9EF1-4904-825A-F5CE8B9B7D65Q30391597-A19AD5E4-E537-49B5-ABC0-D7482DD2BADBQ34345303-ACF2CCAF-2783-43AF-89B0-2072CFC5A6B3Q34535626-C77C143B-6EE4-4B05-8D1D-BFBAE94F8580Q36021845-7F9E54CD-0F69-42A1-8155-2EC05F7B0C6DQ36533915-ABE4A9C7-E8BE-4C46-929A-E5B4D654191DQ38114375-85FEC257-BE5B-495A-A25F-34BDD5DACDC1Q38317793-52F960E5-207B-40F5-BABE-53A4DC31DD0DQ38364898-005B17B2-129D-405A-A9F3-4AA3E802942AQ38565317-6FADFAAE-CE6D-43FD-AF63-4F8D071EC245Q39316545-EEBDE41C-F10E-491F-B5A4-CA26BED60E0BQ39644540-3063D300-480F-4DB9-8292-486A96290F09Q40524568-252811EF-5182-4938-BFCB-8760648386BEQ43469221-023FAD56-DD84-4D4B-BE82-A9DF7F4ADF55Q43872436-B5211D99-1DD6-40D4-ADDB-71BCC94485DFQ47740636-3B61C180-3A0A-41AE-AAFD-F251CA53E1C8Q49275434-541CC6F0-050A-4A88-87C4-A2E36016B6FBQ50229295-430E5695-E8D1-4B48-AE28-E1973ABED973Q50271586-87A71F3D-074D-42B3-AB5C-9EF09B5F96ECQ53091843-9EF52C99-7BE3-4745-A4E0-381B28CD6D50Q53589435-A57380A3-0077-4F9D-8AEE-FC4065E027A3Q56927575-6FA514C2-CA3D-4B79-AC74-5F46FFBB6218Q58106704-9608B319-9DCD-47E8-9CF9-C8176F1FB443Q58308698-5B67FFC9-7572-40E4-A843-5EADF7A5EB49Q59136266-A6924D8F-CC92-4B8F-90ED-8D1344815259
P2860
NSGC practice guideline: prenatal screening and diagnostic testing options for chromosome aneuploidy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
NSGC practice guideline: prena ...... ons for chromosome aneuploidy.
@en
NSGC practice guideline: prena ...... ons for chromosome aneuploidy.
@nl
type
label
NSGC practice guideline: prena ...... ons for chromosome aneuploidy.
@en
NSGC practice guideline: prena ...... ons for chromosome aneuploidy.
@nl
prefLabel
NSGC practice guideline: prena ...... ons for chromosome aneuploidy.
@en
NSGC practice guideline: prena ...... ons for chromosome aneuploidy.
@nl
P2093
P2860
P1476
NSGC practice guideline: prena ...... ons for chromosome aneuploidy.
@en
P2093
A Harbison
C M Sullivan
C N Singletary
J L Czerwinski
J M Hoskovec
K L Wilson
M W Campion
S J Noblin
P2860
P356
10.1007/S10897-012-9545-3
P577
2012-11-22T00:00:00Z